Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 28;10(12):1022.
doi: 10.3390/diagnostics10121022.

A Systematic Review of Pharmacologic and Rehabilitative Treatment of Small Fiber Neuropathies

Affiliations
Review

A Systematic Review of Pharmacologic and Rehabilitative Treatment of Small Fiber Neuropathies

Michele Vecchio et al. Diagnostics (Basel). .

Abstract

The aim of this systematic review is to guide the physician in defining the pharmacologic and rehabilitative therapeutic approaches for adopting the best strategies described in the current literature. The search was conducted in PubMed, EMBASE, Cochrane Library and Web of Science to identify the treatment of small fiber neuropathies. Two reviewers independently reviewed and came to a consensus on which articles met inclusion/exclusion criteria. The authors excluded the duplicates, animal studies and included the English articles in which the treatment of patients with small fiber neuropathies was described. The search identified a total of 975 articles with the keywords "small fiber neuropathy" AND "rehabilitation" OR "therapy" OR "treatment". Seventy-eight selected full-text were analyzed by the reviewers. Forty-two publications met the inclusion criteria and were included in the systematic review to describe the rehabilitative and pharmacologic treatment of small fiber neuropathies. Despite the range of different protocols of treatment for small fiber neuropathy, other robust trials are needed. In addition, always different therapeutic approaches are used; a unique protocol could be important for the clinicians. More research is needed to build evidence for the best strategy and to delineate a definitive therapeutic protocol.

Keywords: small fiber neuropathy; systematic reviews; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of the process of literature search and extraction of studies meeting the inclusion criteria.

Similar articles

Cited by

References

    1. Bakkers M., Faber C.G., Hoeijmakes J.G.J., Lauria G., Merkies I.S.J. Small Fibers, Large Impact: Quality of Life in Small-Fiber Neuropathy. Muscle Nerve. 2014;49:329–336. doi: 10.1002/mus.23910. - DOI - PubMed
    1. Shamseer L., Moher D., Clarke M., Ghersi D., Liberati A., Petticrew M., Shekelle P., Stewart L.A. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ. 2015;350:7647. doi: 10.1136/bmj.g7647. - DOI - PubMed
    1. Higgins J.P., Altman D.G., Gøtzsche P.C., Jüni P., Moher D., Oxman A.D., Savović J., Schulz K.F., Weeks L., Sterne J.A. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Br. Med. J. 2011;343:889–893. doi: 10.1136/bmj.d5928. - DOI - PMC - PubMed
    1. Anderson D., Beecher G., Power C., Bridgland L., Zochodne D.W. A Neuropathic Pain Syndrome Associated With Hantavirus Infection. J. Neurovirol. 2017;23:919–921. doi: 10.1007/s13365-017-0576-2. - DOI - PMC - PubMed
    1. Apfel S.C., Schwartz S., Adornato B.T., Freeman R., Biton V., Rendell M., Vinik A., Giuliani M., Stevens J.C., Barbano R., et al. Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic Polyneuropathy: A Randomized Controlled Trial. rhNGF Clinical Investigator Group. JAMA. 2000;284:2215–2221. doi: 10.1001/jama.284.17.2215. - DOI - PubMed

LinkOut - more resources